Page 9 - Pharmaceutical Companies
Covid-19 prescription: Pharma players shift their focus over the counter
The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment
 "Covid-19 prescription: Pharma players shift their focus over the counter")
Firms and lenders provisions for Covid-related losses cross Rs 27,000 cr
Inventory, impairment losses also run into thousands of crores across March and June, Business Standard analysis shows
 "Firms and lenders provisions for Covid-related losses cross Rs 27,000 cr")
Chemist body warns against Amazon's entry into online pharmacy space
The letter has also been addressed to Prime Minister Narendra Modi, Union Home Minister Amit Shah and other top ministers and government officials
 "Chemist body warns against Amazon's entry into online pharmacy space")
Gilead puts $2,340 price tag for coronavirus drug, faces criticism
The maker of a drug shown to shorten recovery time for severely ill patients says it will charge $2,340 for a typical treatment course for people covered by govt health programmes in the US
 "Gilead puts $2,340 price tag for coronavirus drug, faces criticism")
Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing
Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing
Lincoln Pharma gets entry into Europe, will sell derma, gastro drugs
Receives Germany's GMP certification for its Khatraj plant, can sell to all 27 EU markets
 "Lincoln Pharma gets entry into Europe, will sell derma, gastro drugs")
Four in a lift, facing the wall: Office etiquette in Covid-19 times
The second of a 3-part series discusses precautions taken by firms to keep employees safe
 "Four in a lift, facing the wall: Office etiquette in Covid-19 times")
Surge in demand for preventive drugs seen post lockdown, Ayurveda in focus
Country is testing to see if herbal medicines such as ashwagandha can act as preventive instead of HCQ for Covid-19
 "Surge in demand for preventive drugs seen post lockdown, Ayurveda in focus")
Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch
Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation
Taking a nap, playing ludo: Gujarat pharma hub hit by near-zero exports
Companies finding it tough to source raw materials amid the lockdown
 "Taking a nap, playing ludo: Gujarat pharma hub hit by near-zero exports")
Shot in the arm: Pharma sales clock double-digit growth in February
Amid Coronavirus fears, sales of antibiotics, paracetamol, and respiratory drugs see a spike
 "Shot in the arm: Pharma sales clock double-digit growth in February")
'Drugs imported from unregistered dealers cannot be sold to local buyers'
In my opinion, the shipments made within the original or extended EO period can be counted towards discharge of EO, regardless of when you made the application for EO extension
 "'Drugs imported from unregistered dealers cannot be sold to local buyers'")
Dr Reddy's to acquire part of Wockhardt's India business for Rs 1,850 crore
The agreement comprises a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, and dermatology.
 "Dr Reddy's to acquire part of Wockhardt's India business for Rs 1,850 crore")
Govt may impose anti-dumping duty on a Chinese medicine for infections
Aarti Drugs Ltd has filed an application before the directorate for investigation into the imports from the neighbouring country
 "Govt may impose anti-dumping duty on a Chinese medicine for infections")
Sun Pharma gets partial relief from US court in litigation on generic drugs
Shares of the company on Monday ended 2.18 per cent lower at Rs 440 apiece on the BSE
 "Sun Pharma gets partial relief from US court in litigation on generic drugs")
Biocon to set up R&D facility in India to boost biosimilars development
Biocon has acquired some assets from Pfizer Healthcare to set up its second R&D plant in India
 "Biocon to set up R&D facility in India to boost biosimilars development")
Indian companies giving MNCs a run for their money in vitamins
Three of top five pharmaceutical companies by market share based in India
 "Indian companies giving MNCs a run for their money in vitamins")
One year later, pharma industry bounces back to double-digit growth in May
In May, price growth for drugs was in negative territory at (-)1 per cent
 "One year later, pharma industry bounces back to double-digit growth in May")
Indian pharma's Chinese crisis: Firms fear profit hit on cost hikes
The high dependence on Chinese imports has also been dubbed as a health security risk
 "Indian pharma's Chinese crisis: Firms fear profit hit on cost hikes")
Nearly half of pharma industry may come under price control
DPCO 2013 that lists drugs under price control already includes 18 per cent drugs sold in domestic market
 "Nearly half of pharma industry may come under price control")